AnticoagEvaluator 17+

American College of Cardiology

Designed for iPad

    • 3.0 • 2 Ratings
    • Free



Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at

What’s New

Version 3.0

This version includes the following:
1)  2019 AFib Guideline Update content
2)  Design updates

Ratings and Reviews

3.0 out of 5
2 Ratings

2 Ratings

HalbeDoktor ,

Top of the screen

Agree with the first review
Top email and risk summary are hidden behind battery and time

pkilaru ,

Temporary Workaround

It's become less functional since the IOS 8; you can no longer choose a therapy and see the details of its usefulness or the lack thereof. However, here is temporary workaround until they fix it: after selecting the risk factors for your patient, you click on the email icon and it will give you the relative risk reductions for all of the therapies.
I know it's inelegant but is still functional.
Hopefully, they will fix it soon.

Cadiovention1 ,

Current version fails

Ios8 version does not work

App Privacy

The developer, American College of Cardiology, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.

More By This Developer


You Might Also Like